Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6

被引：0
|
作者：
Russell-Jones, D. [1 ]
Babazono, T. [2 ]
Cailleteau, R. [3 ]
Engberg, S. [3 ]
Irace, C. [4 ]
Kjaersgaard, M. I. S. [5 ]
Mathieu, C. [6 ]
Rosenstock, J. [7 ]
Woo, V. [8 ]
Klonoff, D. C. [9 ]
机构：
[1] Univ Surrey, Dept Endocrinol & Diabet, Guildford, Surrey, England
[2] Tokyo Womens Med Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[3] Novo Nordisk AS, Soborg, Denmark
[4] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa, Catanzaro, Italy
[5] Novo Nordisk AS, Aalborg, Denmark
[6] Univ Leuven, Clin & Expt Endocrinol, Leuven, Belgium
[7] Velocity Clin Res Med City, Dallas, TX USA
[8] Univ Manitoba, Winnipeg, MB, Canada
[9] Mills Peninsula Med Ctr, Diabet Res Inst, San Mateo, CA USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
9
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist use: ONWARDS 1-5
    Vilsboll, T.
    Bangsgaard, K. O.
    Fu, A.
    Kellerer, M.
    Sogaard, S. B.
    Goldenberg, R.
    DIABETOLOGIA, 2024, 67 : S9 - S9
  • [32] Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
    Philis-Tsimikas, Athena
    Asong, Marisse
    Franek, Edward
    Jia, Ting
    Rosenstock, Julio
    Stachlewska, Karolina
    Watada, Hirotaka
    Kellerer, Monika
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (06): : 414 - 425
  • [33] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [34] Once-weekly insulin icodec and hospitalisation: insights from the ONWARDS 1-6 trials
    Philis-Tsimikas, A.
    Bache, J. K.
    Bari, T. J.
    Salvesen-Sykes, K.
    Kellerer, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S401 - S401
  • [35] Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
    Saleem, Syed Zia
    Fareed, Areeba
    Akhtar, Syed Muhammad Muneeb
    Farhat, Solay
    Taha, Amira Mohamed
    Akilimali, Aymar
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [36] Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
    Syed Zia Saleem
    Areeba Fareed
    Syed Muhammad Muneeb Akhtar
    Solay Farhat
    Amira Mohamed Taha
    Aymar Akilimali
    Diabetology & Metabolic Syndrome, 16
  • [37] Once-weekly insulin icodec: pharmacokinetic and pharmacodynamic properties in type 1 diabetes
    Hoevelmann, U.
    Engberg, S.
    Heise, T.
    Kristensen, N. R.
    Norgreen, L.
    Ribel-Madsen, R.
    Zijlstra, E.
    Haahr, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S399 - S400
  • [38] Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trials
    Rossing, Peter
    Benamar, Malik
    Cheng, Alice Y. Y.
    Kumar, Bharath
    Laugesen, Christian
    Bajaj, Harpreet S.
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2259 - 2270
  • [39] The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon
    Carstensen, Lisbeth
    Rocha, Thais M. Pagliaro
    Watt, Sara Kehlet
    Woo, Vincent C.
    DIABETOLOGIA, 2025,
  • [40] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon R.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Woo, Vincent C.
    DIABETES, 2024, 73
12345